CAH — Cardinal Health Income Statement
0.000.00%
- $35.65bn
- $40.45bn
- $222.58bn
- 70
- 68
- 95
- 92
Annual income statement for Cardinal Health, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2021 June 30th | R2022 June 30th | R2023 June 30th | 2024 June 30th | 2025 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 162,467 | 181,326 | 204,979 | 226,827 | 222,578 |
Cost of Revenue | |||||
Gross Profit | 6,778 | 6,484 | 6,874 | 7,414 | 8,168 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 162,009 | 181,943 | 204,227 | 225,584 | 220,303 |
Operating Profit | 458 | -617 | 752 | 1,243 | 2,275 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 323 | -784 | 663 | 1,201 | 2,101 |
Provision for Income Taxes | |||||
Net Income After Taxes | 612 | -937 | 331 | 853 | 1,569 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 611 | -938 | 330 | 852 | 1,561 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 611 | -938 | 330 | 852 | 1,561 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.02 | 4.29 | 5.08 | 6.75 | 6.99 |
Dividends per Share |